Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 3.07x is 22% above its 4-year average of 2.52x, near the low end of its 4-year range (1.14x–20.18x).
6.44% above its 12-month average of 2.88x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): 2.04x.
INTEREST COVERAGE RATIO
3.07x
INTEREST COVERAGE RATIO AVG TTM
2.88x
INTEREST COVERAGE RATIO AVG 3Y
2.27x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.44%
CURRENT VS 3Y AVG
+35.52%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 476 covered companies
CURRENT VS SECTOR MEDIAN
+153.02%
vs the sector median at left
Embecta Corp.
Market Cap
$359.28M
Interest Coverage Ratio
3.07x
TTM Avg
2.88x
3Y Avg
2.27x
5Y Avg
N/A
Market Cap
$359.09M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$357.76M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$355.36M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$354.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$363.70M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$352.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$351.50M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.11M
Interest Coverage Ratio
-1.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Embecta Corp. (EMBC) | $359.28M | 3.07x | 2.88x | 2.27x | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $359.09M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Ocugen, Inc. (OCGN)vs › | $357.76M | -12.13x | 372.18x | 320.22x | 320.22x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.36M | -3.05x | 0.61x | 0.61x | 0.61x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.14M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $363.70M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $352.43M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $351.50M | -45.13x | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $374.11M | -1.91x | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $379.73M | N/A | 4.06x | 4.06x | 4.06x |
Interest Coverage
3.1x
Debt/Equity
N/A
Current Ratio
1.68
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.04x |
| 2026-03-31 | 1.90x |
| 2025-12-31 | 4.03x |
| 2025-09-30 | 2.47x |
| 2025-06-30 | 3.99x |
| 2025-03-31 | 2.94x |
| 2024-12-31 | 2.76x |
| 2024-09-30 | 1.16x |
| 2024-06-30 | 2.01x |
| 2024-03-31 | 1.41x |
| 2023-12-31 | 1.71x |
| 2023-09-30 | 1.14x |
| 2023-06-30 | 1.90x |
| 2023-03-31 | 2.07x |
| 2022-12-31 | 3.47x |
| 2022-09-30 | 2.89x |
| 2022-06-30 | 4.98x |
| 2022-03-31 | 20.18x |
